Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Heptares doses first subject in Alzheimer’s drug trial

pharmatimesSeptember 04, 2017

Tag: Alzheimer , Heptares

PharmaSources Customer Service